HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zuzana Diamant Selected Research

CNTO3157

1/2018Toll-like receptor 3 blockade in rhinovirus-induced experimental asthma exacerbations: A randomized controlled study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zuzana Diamant Research Topics

Disease

56Asthma (Bronchial Asthma)
03/2022 - 01/2004
17Inflammation (Inflammations)
03/2022 - 06/2005
10Hypersensitivity (Allergy)
04/2022 - 01/2004
7COVID-19
01/2022 - 05/2020
6Allergic Rhinitis
01/2022 - 01/2004
6Chronic Obstructive Pulmonary Disease (COPD)
01/2021 - 08/2011
4Respiratory Hypersensitivity
03/2022 - 03/2007
2Infections
09/2022 - 01/2021
2Airway Remodeling
01/2022 - 01/2009
2Respiratory Tract Infections (Respiratory Tract Infection)
01/2022 - 01/2016
2Virus Diseases (Viral Diseases)
01/2022 - 12/2020
2Food Hypersensitivity (Food Allergy)
12/2020 - 12/2019
2Drug Hypersensitivity (Drug Allergy)
12/2020 - 12/2019
2Respiratory Tract Diseases (Respiratory Tract Disease)
12/2019 - 01/2019
2Eosinophilia
01/2016 - 10/2012
1Airway Obstruction (Choking)
03/2022
1Pneumonia (Pneumonitis)
01/2021
1Dyspnea (Shortness of Breath)
01/2021
1Leukemia
01/2021
1Communicable Diseases (Infectious Diseases)
01/2021
1Respiratory Insufficiency (Respiratory Failure)
01/2021
1Autoimmune Diseases (Autoimmune Disease)
01/2021
1Lymphoma (Lymphomas)
01/2021
1Lung Diseases (Lung Disease)
01/2021
1Urticaria (Hives)
12/2020
1Atopic Dermatitis (Atopic Eczema)
12/2020
1Anaphylaxis (Anaphylactic Shock)
12/2020
1Rhinosinusitis
12/2020
1Systemic Mastocytosis
08/2020
1Rhinitis
12/2019
1Weight Loss (Weight Reduction)
01/2015
1Overweight
01/2015

Drug/Important Bio-Agent (IBA)

14Biomarkers (Surrogate Marker)IBA
01/2021 - 06/2005
13Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 01/2004
11AllergensIBA
04/2022 - 03/2007
8Biological ProductsIBA
01/2022 - 03/2007
6Pharmaceutical PreparationsIBA
09/2022 - 03/2008
6Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2021 - 10/2012
5Immunoglobulin E (IgE)IBA
01/2021 - 01/2004
3Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA
01/2022 - 06/2005
3Prostaglandin D2IBA
01/2022 - 12/2014
3Bronchodilator Agents (Bronchodilators)IBA
04/2021 - 08/2011
3Mometasone Furoate (Nasonex)FDA LinkGeneric
04/2021 - 04/2020
3Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric
04/2021 - 04/2020
3indacaterolIBA
04/2021 - 04/2020
3LeukotrienesIBA
01/2021 - 01/2004
3Interleukin-13IBA
01/2018 - 01/2016
3CytokinesIBA
01/2017 - 01/2004
2EicosanoidsIBA
01/2022 - 01/2021
2Acetates (Acetic Acid Esters)FDA Link
04/2021 - 01/2021
2ProstaglandinsIBA
01/2021 - 01/2019
2LipidsIBA
01/2021 - 01/2019
2VaccinesIBA
01/2021 - 10/2020
2InterleukinsIBA
01/2018 - 01/2017
2Interleukin-4 Receptors (Interleukin 4 Receptor)IBA
01/2018 - 01/2004
2PeriostinIBA
01/2018 - 01/2016
2Interleukin-5 (Interleukin 5)IBA
01/2017 - 01/2016
2Methacholine Chloride (Methacholine)FDA Link
11/2013 - 01/2005
2Neurokinin AIBA
03/2007 - 01/2005
2TachykininsIBA
03/2007 - 01/2005
2Substance PIBA
03/2007 - 01/2005
2Neurokinin-2 Receptors (Neurokinin 2 Receptor)IBA
03/2007 - 01/2005
1Proteins (Proteins, Gene)FDA Link
03/2022
1Protease Inhibitors (Protease Inhibitor)IBA
03/2022
1ProteomeIBA
03/2022
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2022
1CannabinoidsIBA
01/2022
1Analgesics (Analgesic Drugs)IBA
01/2022
1EmollientsIBA
01/2022
1Antiviral Agents (Antivirals)IBA
01/2022
1AntipyreticsIBA
01/2022
1Immunologic Factors (Immunomodulators)IBA
01/2022
1Muscarinic AntagonistsIBA
04/2021
1GoldIBA
01/2021
1Matrix Metalloproteinase 12IBA
01/2021
1prostaglandin D2 receptorIBA
01/2021
1EnoximoneIBA
01/2021
1Leukotriene Receptors (Leukotriene Receptor)IBA
01/2021
1ThromboxanesIBA
01/2021
1LipoxinsIBA
01/2021
1Air Pollutants (Pollutants, Air)IBA
01/2021
1Salmeterol Xinafoate (Serevent)FDA Link
04/2020
1Fluticasone (Cutivate)FDA LinkGeneric
04/2020
1anti-IgE antibodiesIBA
12/2019
1lebrikizumabIBA
01/2018
1CNTO3157IBA
01/2018
1dupilumabIBA
01/2018
1tralokinumabIBA
01/2018
1Pattern Recognition ReceptorsIBA
01/2018
1Toll-Like Receptor 3IBA
01/2018
1Interleukin-4 (Interleukin 4)IBA
01/2018
1SteroidsIBA
01/2017

Therapy/Procedure

29Therapeutics
01/2022 - 01/2004
6Precision Medicine
01/2021 - 01/2017
3Drug Therapy (Chemotherapy)
01/2021 - 10/2013
3Immunotherapy
05/2020 - 05/2013
3Biological Therapy
12/2019 - 01/2017
1Artificial Respiration (Mechanical Ventilation)
01/2021
1Transplantation
01/2021
1Nebulizers and Vaporizers (Inhaler)
08/2020